| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Mainstream news |
| Population | Women |
| Source | blue News (bluewin.ch) |
| URL | bluewin.ch/en/news/it-s-not-just-important-for-men-why-more-and-more-women-are-taking-testosterone-li.3592391 (opens in a new tab) |
Specific Claim Evaluated
Testosterone in women falls gradually from age 30 to 40 with a marked drop during menopause, and deficiency causes fatigue, low energy, low mood and reduced self-confidence.
Primary Research Supporting or Contradicting the Claim
Testosterone in midlife women varies with age rather than menopausal stage (Wang et al., 2025). The consensus statement found no level that defines deficiency in women and no evidence to treat symptoms other than hypoactive sexual desire disorder (Davis et al., 2019).
Corrected Evidence-Based Interpretation
Testosterone in women declines gradually with age without a marked menopausal drop. There is no diagnosable testosterone deficiency syndrome in women based on fatigue or mood, and treatment is indicated only for postmenopausal hypoactive sexual desire disorder.
Rationale for Grade
The article presents a menopausal drop and a set of nonspecific deficiency symptoms as fact, quoting a single researcher. Both claims are contradicted by the primary evidence. The article does note the absence of approved products and long-term safety data.
References
- Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID
Supporting excerpt: "The only evidence-based indication for testosterone for women is for HSDD." - Wang Y, Islam RM, Bond M, Davis SR. Testosterone and pre-androgens by age and menopausal stage at midlife: findings from a cross-sectional study. EBioMedicine. 2025;121:105972. PMID
Supporting excerpt: "These data do not support menopause per se as an indication for testosterone supplementation."